On the surface, the 1986 Draft looks fairly typical with three Hall-of-Fame members (i.e. Dennis Rodman, Arvydas Sabonis, and Drazen Petrovic) and three additional All Stars (i.e. Brad Daugherty, Mark Price, and Jeff Hornacek); however, things are not always as they appear. Instead of being remembered for any of these players, that draft is associated most often with players on the opposite end of the spectrum. In particular, four of the top seven draft picks had their careers end prematurely because of problems with drugs. I have highlighted the sad stories of Len Bias (#2), William Bedford (#6), and Roy Tarpley (#7) in previous posts, but this one is reserved for Chris Washburn (#3), who is the NBA’s #1 Drug (err, Draft) Bust.
In the 1996 NBA Draft, the Golden State Warriors selected Todd Fuller with the 11th overall pick. Despite being a lottery selection, Fuller didn’t live up to expectations. Of note, he finished his NBA career with 835 points and 674 rebounds. Even worse, the Warriors selected him over future Hall-of-Famers Kobe Bryant and Steve Nash. As such, Fuller should be remembered as one of the all-time worst draft picks. Still, the former 1st Team All-ACC honoree shouldn’t be considered a Top 10 Bust. In particular, he just wasn’t drafted high enough to warrant the “honor.”
Taken with the 9th overall pick in the 2006 NBA Draft, Patrick O’Bryant finished his career with fewer than 200 points and 150 rebounds. Based on a total 0f 0.5 career win shares, he ranks in the bottom 3% of all 6th-10th overall picks since 1970. As such, the former Bradley Brave failed on an absolute and relative basis. Worthy of being labeled an all-time bust, O’Bryant escapes the Hall of Shame given that Adam Morrison went earlier in the same draft. Without the same cachet, O’Bryant must settle for an Honorable Mention. Somehow, I’m sure he’ll manage.